Clinical Trial Update: Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the combination of a PD-1 inhibitor with decitabine for elderly patients with relapse/refractory acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)
• PD-1 inhibitor

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN